Investing
First Look Analyst Calls Briefing for Wednesday, November 2, 2022
Published:
Last Updated:
This report was sent to Briefing.com subscribers earlier today.
> Red Electrica (RDEIY) upgraded to Hold from Sell at Berenberg
> Abiomed (ABMD) downgraded to Hold from Buy at Deutsche Bank; tgt raised to $388
> Bally’s Corporation (BALY) downgraded to Hold from Buy at Stifel; tgt lowered to $25
> British American Tobacco (BTI) downgraded to Neutral from Buy at Goldman
> Cleveland-Cliffs (CLF) downgraded to Underperform from Peer Perform at Wolfe Research; tgt $12
> Ecolab (ECL) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $135
> NASDAQ (NDAQ) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $57
> Semler Scientific (SMLR) downgraded to Neutral from Buy at B. Riley Securities; tgt lowered to $45
> Universal Logistics (ULH) downgraded to Hold from Buy at Stifel; tgt $36
> Aeva (AEVA) initiated with a Hold at WestPark Capital; tgt $3
> AEye (LIDR) initiated with a Hold at WestPark Capital; tgt $1
> Canopy Growth (CGC) initiated with an Underperform at Bernstein; tgt $1.50
> Check Point Software (CHKP) initiated with a Neutral at Macquarie; tgt $129
> Cloudflare (NET) initiated with a Neutral at Macquarie; tgt $60
> CrowdStrike (CRWD) initiated with an Outperform at Macquarie; tgt $220
> Datadog (DDOG) initiated with a Neutral at Macquarie; tgt $85
> Dynatrace (DT) initiated with a Neutral at Macquarie; tgt $38
> HubSpot (HUBS) initiated with an Outperform at Macquarie; tgt $355
> Innoviz Technologies (INVZ) initiated with a Buy at WestPark Capital; tgt $12
> Legend Biotech (LEGN) initiated with an Outperform at Evercore ISI
> Lineage Cell Therapeutics (LCTX) initiated with an Outperform at Robert W. Baird; tgt $5
> Luminar Technologies (LAZR) initiated with a Buy at WestPark Capital; tgt $14
> Microsoft (MSFT) initiated with a Neutral at Macquarie; tgt $234
> nCino (NCNO) assumed with an Outperform at Macquarie; tgt $42
> Okta (OKTA) initiated with a Neutral at Macquarie; tgt $60
> Ouster (OUST) initiated with a Buy at WestPark Capital; tgt $4
> Palo Alto Networks (PANW) initiated with a Neutral at Macquarie; tgt $185
> Salesforce (CRM) assumed with an Outperform at Macquarie; tgt $210
> ServiceNow (NOW) assumed with an Outperform at Macquarie; tgt $500
> Snowflake (SNOW) initiated with a Neutral at Macquarie; tgt $173
> Sorrento Therapeutics (SRNE) initiated with an Overweight at Cantor Fitzgerald; tgt $5
> Velodyne Lidar (VLDR) initiated with an Underperform at WestPark Capital
> Workday (WDAY) initiated with a Neutral at Macquarie; tgt $170
> Zscaler (ZS) initiated with a Neutral at Macquarie; tgt $155
Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.
A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.
Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.